Heterogeneous expression of CD31 molecules on CECs and some CTCs, as well as circulating tumor microemboli (CTM) reported in this study, suggests that aneuploid CD31+ cells under pathologic circumstances may have diverse characteristics comparing to the conventional categories of CD31+ cells. The gene discussed is PECAM1; the disease is neoplasm.